"Antimicrobial resistance—and the debate on their judicious use—is an important issue facing veterinary medicine today. This committee was assembled to help the FDA examine both the need for increased veterinary oversight in order to minimize any potential increase in human antibiotic resistance while still ensuring that these important medicines continue to remain available to veterinarians when needed," said
Dr. John Brooks, chair of the AVMA Executive Board. "Each of these members was selected for their understanding of this delicate balance and for their ability to tackle tough issues objectively with the public well-being in mind."